Biopharmaceutical firm Lyvgen has raised “tens of millions of US dollars” in a Series C round led by IDG Capital, while AI accelerator Beijing VirtAI Technology has pocketed a similar amount in its Series A+ round led by China Mobile’s joint fund.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
